Top

Tag: vaccines


Industry, News, Vaccines

Biden moves deadline for states to open Covid vaccines to all U.S. adults to April 19

April 6, 2021

Via: CNBC

President Joe Biden announced Tuesday that states should open Covid-19 vaccine appointments to all U.S. adults by April 19, moving up his original deadline by nearly two weeks. Biden announced the new deadline after he visited a vaccination site in […]


Biotech, Cell and Gene Therapy, Industry

HitGen and BioAge Announce Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration

April 6, 2021

Via: BioSpace

Shanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted […]


Biotech, Industry, Manufacturing, News, Research and Development, Vaccines

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments

April 5, 2021

Via: BioSpace

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]


Industry, News, Vaccines

COVID-19 Vaccine Market: Nucleic acid vaccines segment to dominate global market

April 2, 2021

Via: BioSpace

COVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate […]


Clinical Trials, News, Research and Development

Study identifies possible COVID-19 drugs — including several that are FDA-approved

April 2, 2021

Via: ScienceDaily

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. […]


Industry, Vaccines

Manufacturing mix-up could blunt supply boost from J&J vaccine

April 1, 2021

Via: Biopharma Dive

The FDA’s emergency authorization of J&J’s vaccine late last month boosted the quickening rollout of vaccines in the U.S., adding a third option in addition to shots from Pfizer and Moderna. Yet, previous delays in manufacturing meant J&J only had […]


Industry, Manufacturing, Research and Development, Vaccines

Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna

March 29, 2021

Via: World Pharma News

EMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU. New manufacturing site for AstraZeneca’s COVID-19 vaccine A new manufacturing site has been approved for the production […]


Industry, News, Vaccines

Updated Statement on Covid-19 Vaccines and Thrombosis From Thrombosis Canada

March 19, 2021

Via: BioSpace

Thrombosis Canada has reviewed recent reports from the United Kingdom and Europe relating to the SARS-CoV-2 (COVID-19) vaccine made by AstraZeneca and the development of a very rare type of thrombosis (blood clots) that is associated with thrombocytopenia (low blood […]


Clinical Trials, Industry, Research and Development, Vaccines

Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results in Non-Human Primates Vaccinated with TNX-1800 and Challenged with Live SARS-CoV-2

March 17, 2021

Via: BioSpace

Tonix Pharmaceuticals, Inc.. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced preliminary results following vaccination of non-human primates with TNX-1800 (modified horsepox virus, live vaccine), a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 […]


News

Decades-Old Leprosy Drug Inhibits Coronaviruses, May Treat COVID-19

March 17, 2021

Via: Genetic Engineering and Biotechnology News

With treatments for COVID-19 lacking, researchers are homing in on drugs that are already FDA approved to search for candidates that may inhibit SARS-CoV-2 replication. This method, known as repurposing, has found that clofazimine, an anti-leprosy drug, exhibits potent antiviral […]


Industry, News, Vaccines

European Union countries clash over unequal vaccine distribution

March 15, 2021

Via: CNBC

Six members of the European Union have raised concerns over how the bloc is distributing Covid-19 vaccines, after AstraZeneca cut its delivery targets once again. Austria, Latvia, the Czech Republic, Bulgaria, Croatia and Slovenia wrote to the European Commission on […]


Industry, News, Vaccines

Britain denies ‘completely false’ EU claims as a new vaccine dispute boils over

March 10, 2021

Via: CNBC

The European Union and the United Kingdom have clashed over the export of coronavirus vaccines, with Britain fiercely denying it has blocked any shipments to other nations. The latest battle emerged after European Council President Charles Michel accused the U.K. […]